PL4574996T3 - Wykrywanie i leczenie chorób wykazujących heterogeniczność komórek chorobowych oraz systemy i sposoby przekazywania wyników testów - Google Patents
Wykrywanie i leczenie chorób wykazujących heterogeniczność komórek chorobowych oraz systemy i sposoby przekazywania wyników testówInfo
- Publication number
- PL4574996T3 PL4574996T3 PL25155747.6T PL25155747T PL4574996T3 PL 4574996 T3 PL4574996 T3 PL 4574996T3 PL 25155747 T PL25155747 T PL 25155747T PL 4574996 T3 PL4574996 T3 PL 4574996T3
- Authority
- PL
- Poland
- Prior art keywords
- systems
- detection
- treatment
- methods
- test results
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Biomedical Technology (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462098426P | 2014-12-31 | 2014-12-31 | |
| US201562155763P | 2015-05-01 | 2015-05-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4574996T3 true PL4574996T3 (pl) | 2026-03-02 |
Family
ID=56284976
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL25155747.6T PL4574996T3 (pl) | 2014-12-31 | 2015-12-28 | Wykrywanie i leczenie chorób wykazujących heterogeniczność komórek chorobowych oraz systemy i sposoby przekazywania wyników testów |
Country Status (9)
| Country | Link |
|---|---|
| US (5) | US20170260590A1 (pl) |
| EP (5) | EP3240911B1 (pl) |
| JP (4) | JP6783768B2 (pl) |
| CN (2) | CN113930507A (pl) |
| AU (3) | AU2015374259B2 (pl) |
| ES (3) | ES2828279T3 (pl) |
| GB (1) | GB2552267B (pl) |
| PL (1) | PL4574996T3 (pl) |
| WO (1) | WO2016109452A1 (pl) |
Families Citing this family (73)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3246416T3 (pl) | 2011-04-15 | 2024-09-30 | The Johns Hopkins University | Bezpieczny system sekwencjonowania |
| US9892230B2 (en) | 2012-03-08 | 2018-02-13 | The Chinese University Of Hong Kong | Size-based analysis of fetal or tumor DNA fraction in plasma |
| CN109457030B (zh) | 2012-10-29 | 2022-02-18 | 约翰·霍普金斯大学 | 卵巢和子宫内膜癌的帕帕尼科拉乌测试 |
| HK1213944A1 (zh) | 2012-12-10 | 2016-07-15 | Resolution Bioscience, Inc. | 用於靶向基因组分析 |
| US11062789B2 (en) | 2014-07-18 | 2021-07-13 | The Chinese University Of Hong Kong | Methylation pattern analysis of tissues in a DNA mixture |
| US20160053301A1 (en) | 2014-08-22 | 2016-02-25 | Clearfork Bioscience, Inc. | Methods for quantitative genetic analysis of cell free dna |
| EP3240911B1 (en) * | 2014-12-31 | 2020-08-26 | Guardant Health, Inc. | Detection and treatment of disease exhibiting disease cell heterogeneity and systems and methods for communicating test results |
| US10364467B2 (en) | 2015-01-13 | 2019-07-30 | The Chinese University Of Hong Kong | Using size and number aberrations in plasma DNA for detecting cancer |
| JP6829211B2 (ja) | 2015-02-10 | 2021-02-10 | ザ チャイニーズ ユニバーシティ オブ ホンコン | 癌スクリーニング及び胎児分析のための変異検出 |
| PT3325664T (pt) | 2015-07-23 | 2022-03-03 | Univ Hong Kong Chinese | Análise de padrões de fragmentação de adn sem células |
| US11286531B2 (en) | 2015-08-11 | 2022-03-29 | The Johns Hopkins University | Assaying ovarian cyst fluid |
| EP4462438A3 (en) | 2015-10-09 | 2025-02-26 | Guardant Health, Inc. | Population based treatment recommender using cell free dna |
| JP6913089B2 (ja) | 2015-11-11 | 2021-08-04 | レゾリューション バイオサイエンス， インコーポレイテッド | Ｄｎａライブラリーの高効率構築 |
| WO2017106768A1 (en) | 2015-12-17 | 2017-06-22 | Guardant Health, Inc. | Methods to determine tumor gene copy number by analysis of cell-free dna |
| KR102850460B1 (ko) | 2016-08-25 | 2025-08-27 | 레졸루션 바이오사이언스, 인크. | Dna 샘플 중 게놈 카피 변화의 검출을 위한 방법 |
| KR20240155386A (ko) | 2016-09-30 | 2024-10-28 | 가던트 헬쓰, 인크. | 무세포 핵산의 다중-해상도 분석 방법 |
| US9850523B1 (en) | 2016-09-30 | 2017-12-26 | Guardant Health, Inc. | Methods for multi-resolution analysis of cell-free nucleic acids |
| KR102921023B1 (ko) | 2016-11-30 | 2026-01-30 | 더 차이니즈 유니버시티 오브 홍콩 | 소변 및 기타 샘플에서의 무세포 dna의 분석 |
| MX393780B (es) | 2017-01-17 | 2025-03-24 | Heparegenix Gmbh | Inhibidores de proteina cinasa para promover la regeneracion hepatica o reducir o prevenir la muerte de hepatocitos |
| CA3051509A1 (en) | 2017-01-25 | 2018-08-02 | The Chinese University Of Hong Kong | Diagnostic applications using nucleic acid fragments |
| KR102083501B1 (ko) * | 2017-02-09 | 2020-03-02 | 사회복지법인 삼성생명공익재단 | 종양 치료를 위한 표적 유전자 판별 방법 |
| WO2018201072A2 (en) | 2017-04-28 | 2018-11-01 | 4D Path Inc. | Apparatus, systems, and methods for rapid cancer detection |
| ES2991960T3 (es) * | 2017-05-16 | 2024-12-05 | Guardant Health Inc | Identificación del origen somático o germinal del ADN libre de células |
| US10636512B2 (en) | 2017-07-14 | 2020-04-28 | Cofactor Genomics, Inc. | Immuno-oncology applications using next generation sequencing |
| EP4234723A3 (en) | 2017-07-26 | 2023-09-20 | The Chinese University Of Hong Kong | Enhancement of cancer screening using cell-free viral nucleic acids |
| EP3665308A1 (en) | 2017-08-07 | 2020-06-17 | The Johns Hopkins University | Methods and materials for assessing and treating cancer |
| JP7072825B2 (ja) * | 2017-09-13 | 2022-05-23 | 三菱電機ソフトウエア株式会社 | コピー数計測装置、コピー数計測プログラムおよびコピー数計測方法 |
| SG11202002381TA (en) * | 2017-09-20 | 2020-04-29 | Guardant Health Inc | Methods and systems for differentiating somatic and germline variants |
| EP3704268B1 (en) | 2017-11-03 | 2025-01-22 | Guardant Health, Inc. | Normalizing tumor mutation burden |
| EP3717662A1 (en) * | 2017-11-28 | 2020-10-07 | Grail, Inc. | Models for targeted sequencing |
| AU2018375008B2 (en) | 2017-12-01 | 2024-06-27 | Illumina, Inc. | Methods and systems for determining somatic mutation clonality |
| CA3083787A1 (en) | 2017-12-01 | 2019-06-06 | Personal Genome Diagnositics Inc. | Process for microsatellite instability detection |
| CN108491689B (zh) * | 2018-02-01 | 2019-07-09 | 杭州纽安津生物科技有限公司 | 基于转录组的肿瘤新抗原鉴定方法 |
| CN111684078B (zh) * | 2018-02-12 | 2024-04-19 | 豪夫迈·罗氏有限公司 | 通过评价肿瘤遗传异质性来预测对治疗的应答的方法 |
| KR102929212B1 (ko) * | 2018-02-27 | 2026-02-20 | 코넬 유니버시티 | 잔류 질환의 검출을 위한 시스템 및 방법 |
| JP2021519607A (ja) * | 2018-02-27 | 2021-08-12 | コーネル・ユニバーシティーＣｏｒｎｅｌｌ Ｕｎｉｖｅｒｓｉｔｙ | ゲノムワイド統合による循環腫瘍ｄｎａの超音波感受性検出 |
| GB2587939B (en) | 2018-04-02 | 2023-06-14 | Grail Llc | Methylation markers and targeted methylation probe panels |
| WO2019195769A1 (en) * | 2018-04-06 | 2019-10-10 | The Brigham And Women's Hospital, Inc. | Methods of diagnosing and treating aggressive cutaneous t-cell lymphomas |
| CN112218957B (zh) * | 2018-04-16 | 2025-08-08 | 格里尔公司 | 用于确定在无细胞核酸中的肿瘤分数的系统及方法 |
| US20240254547A1 (en) * | 2018-04-27 | 2024-08-01 | Kao Corporation | Highly accurate sequencing method |
| JP7274504B2 (ja) * | 2018-05-08 | 2023-05-16 | エフ． ホフマン－ラ ロシュ アーゲー | 多様度指数を確立することで腫瘍バリアント多様度を評価することによるがん予後診断の方法 |
| CN120193081A (zh) * | 2018-07-23 | 2025-06-24 | 夸登特健康公司 | 用于通过肿瘤分数和覆盖率调整肿瘤突变负荷的方法和系统 |
| CA3111887A1 (en) | 2018-09-27 | 2020-04-02 | Grail, Inc. | Methylation markers and targeted methylation probe panel |
| GB2577548B (en) * | 2018-09-28 | 2022-10-26 | Siemens Healthcare Gmbh | Method for determining a subject's genetic copy number value |
| CN113168885B (zh) * | 2018-11-13 | 2024-07-16 | 麦利亚德基因公司 | 用于体细胞突变的方法和系统及其用途 |
| CA3118742A1 (en) * | 2018-11-21 | 2020-05-28 | Karius, Inc. | Detection and prediction of infectious disease |
| CN109712671B (zh) * | 2018-12-20 | 2020-06-26 | 北京优迅医学检验实验室有限公司 | 基于ctDNA的基因检测装置、存储介质及计算机系统 |
| WO2020146727A1 (en) * | 2019-01-10 | 2020-07-16 | Selim Olcum | Identifying cancer therapies |
| EP3918089B1 (en) | 2019-01-31 | 2025-01-15 | Guardant Health, Inc. | Method for isolating and sequencing cell-free dna |
| EP3984037A1 (en) * | 2019-06-13 | 2022-04-20 | F. Hoffmann-La Roche AG | Systems and methods with improved user interface for interpreting and visualizing longitudinal data |
| CN110428905B (zh) * | 2019-07-02 | 2022-03-29 | 江南大学附属医院 | 一种肿瘤生长趋势预测方法 |
| JP7342239B2 (ja) * | 2019-07-22 | 2023-09-11 | エフ． ホフマン－ラ ロシュ アーゲー | バリアント呼び出しデータからの起始細胞決定のためのシステムおよび方法 |
| AU2020345621A1 (en) * | 2019-09-09 | 2022-04-07 | University Of Utah Research Foundation | Targeted sequencing to detect and quantify low levels of methylated DNA |
| EP3809414A1 (en) * | 2019-10-15 | 2021-04-21 | Koninklijke Philips N.V. | Method and apparatus for assessing patient's response to therapy |
| CN110895963A (zh) * | 2019-10-31 | 2020-03-20 | 深圳兰丁医学检验实验室 | 一种基于人工智能的细胞dna定量检测系统 |
| BR112022015909A2 (pt) | 2020-02-14 | 2022-10-04 | Univ Johns Hopkins | Métodos e materiais para avaliação de ácidos nucleicos |
| US11211144B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Methods and systems for refining copy number variation in a liquid biopsy assay |
| US11475981B2 (en) | 2020-02-18 | 2022-10-18 | Tempus Labs, Inc. | Methods and systems for dynamic variant thresholding in a liquid biopsy assay |
| US11211147B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing |
| WO2021243303A1 (en) * | 2020-05-29 | 2021-12-02 | Children's National Medical Center | Genetic diagnostic tool for facioscapulohumeral muscular dystrophy (fshd) |
| DE112021004478T5 (de) | 2020-08-25 | 2023-09-14 | Seer, Inc. | Zusammensetzungen und verfahren zur bestimmung von proteinen und nukleinsäuren |
| US20240006080A1 (en) * | 2020-12-07 | 2024-01-04 | Hoffmann-La Roche Inc. | Techniques for generating predictive outcomes relating to oncological lines of therapy using artificial intelligence |
| US12423593B2 (en) * | 2021-06-11 | 2025-09-23 | Massachusetts Institute Of Technology | Systems and methods for synthetic interventions |
| WO2023009857A2 (en) * | 2021-07-30 | 2023-02-02 | Guardant Health, Inc. | Computer architecture for identifying lines of therapy |
| CN114267445B (zh) * | 2021-12-23 | 2024-09-06 | 众阳健康科技集团有限公司 | 一种诊断一致性检验方法、系统、设备及介质 |
| JP7365656B1 (ja) | 2022-02-18 | 2023-10-20 | Dic株式会社 | 硫化オレフィンの製造方法 |
| EP4496905A4 (en) * | 2022-03-23 | 2026-03-18 | Found Medicine Inc | METHODS AND SYSTEMS FOR DETERMINING TUMOR HETEROGENEITY |
| TW202436625A (zh) * | 2023-03-01 | 2024-09-16 | 體學生物科技股份有限公司 | 核酸分子的檢測方法、檢測套組及檢測卡匣 |
| CN116403644B (zh) * | 2023-03-03 | 2023-12-05 | 深圳吉因加信息科技有限公司 | 一种用于癌症风险预测的方法及装置 |
| US20240339215A1 (en) * | 2023-04-06 | 2024-10-10 | Board Of Regents, The University Of Texas System | System and method for drug selection |
| US20240363198A1 (en) * | 2023-04-27 | 2024-10-31 | Cardiai Technologies | System for identifying genetic variants and method thereof |
| CN117219162B (zh) * | 2023-09-12 | 2024-07-02 | 四川大学 | 针对肿瘤组织str图谱进行身源鉴定的证据强度评估方法 |
| USD1118634S1 (en) * | 2023-10-11 | 2026-03-17 | Open Text Inc. | Display screen or portion thereof with graphical user interface for visualizing connections between base entities of a story corresponding to a security issue |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7385605B2 (en) * | 2003-12-04 | 2008-06-10 | International Business Machines Corporation | Computer display system for dynamically modifying stacked area line graphs to change the order or presence of a set of stacked areas in the graph respectively representative of the proportions contributed to a total by each of a set of time dependent variables |
| US20060199189A1 (en) * | 2005-03-07 | 2006-09-07 | Bradford Sherry A | Low-dose, sequenced, individualized chemotherapy dosing method |
| US10095829B2 (en) * | 2009-07-08 | 2018-10-09 | Worldwide Innovative Network | Computer implemented methods of treating lung cancer |
| US20140148350A1 (en) * | 2010-08-18 | 2014-05-29 | David Spetzler | Circulating biomarkers for disease |
| PL3246416T3 (pl) | 2011-04-15 | 2024-09-30 | The Johns Hopkins University | Bezpieczny system sekwencjonowania |
| CA2840149C (en) | 2011-07-08 | 2021-10-26 | Epigenomics Ag | Methods and nucleic acids for determining the prognosis of a cancer subject |
| EP2563937A1 (en) * | 2011-07-26 | 2013-03-06 | Verinata Health, Inc | Method for determining the presence or absence of different aneuploidies in a sample |
| US20130110407A1 (en) * | 2011-09-16 | 2013-05-02 | Complete Genomics, Inc. | Determining variants in genome of a heterogeneous sample |
| SG190466A1 (en) * | 2011-11-18 | 2013-06-28 | Agency Science Tech & Res | Methods for diagnosis and/or prognosis of ovarian cancer |
| DK2828218T3 (da) | 2012-03-20 | 2020-11-02 | Univ Washington Through Its Center For Commercialization | Methods of lowering the error rate of massively parallel dna sequencing using duplex consensus sequencing |
| US11261494B2 (en) * | 2012-06-21 | 2022-03-01 | The Chinese University Of Hong Kong | Method of measuring a fractional concentration of tumor DNA |
| IL269097B2 (en) * | 2012-09-04 | 2024-01-01 | Guardant Health Inc | Systems and methods to detect rare mutations and copy number variation |
| SMT202100256T1 (it) * | 2012-09-20 | 2021-05-07 | Univ Hong Kong Chinese | Determinazione non invasiva di metiloma di tumore dal plasma |
| US20140287937A1 (en) | 2013-02-21 | 2014-09-25 | Toma Biosciences, Inc. | Methods for assessing cancer |
| EP3795696B1 (en) * | 2013-03-15 | 2023-04-26 | The Board of Trustees of the Leland Stanford Junior University | Identification and use of circulating nucleic acid tumor markers |
| EP4439566A3 (en) | 2013-03-15 | 2024-12-04 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| WO2014165549A1 (en) | 2013-04-01 | 2014-10-09 | University Of Florida Research Foundation, Incorporated | Determination of methylation state and chromatin structure of target genetic loci |
| EP3003377A1 (en) * | 2013-05-31 | 2016-04-13 | Novartis AG | Combination therapy containing a pi3k-alpha inhibitor and fgfr kinase inhibitor for treating cancer |
| EP3240911B1 (en) * | 2014-12-31 | 2020-08-26 | Guardant Health, Inc. | Detection and treatment of disease exhibiting disease cell heterogeneity and systems and methods for communicating test results |
| EP4462438A3 (en) * | 2015-10-09 | 2025-02-26 | Guardant Health, Inc. | Population based treatment recommender using cell free dna |
| WO2017106768A1 (en) | 2015-12-17 | 2017-06-22 | Guardant Health, Inc. | Methods to determine tumor gene copy number by analysis of cell-free dna |
| US11384382B2 (en) * | 2016-04-14 | 2022-07-12 | Guardant Health, Inc. | Methods of attaching adapters to sample nucleic acids |
| USD810111S1 (en) * | 2016-09-08 | 2018-02-13 | Sap Se | Electronic display screen with a graphical user interface |
| EP3785269A4 (en) | 2018-03-29 | 2021-12-29 | Freenome Holdings, Inc. | Methods and systems for analyzing microbiota |
| USD1013704S1 (en) * | 2021-07-09 | 2024-02-06 | The Regents Of The University Of Colorado, A Body Corporate | Display screen or portion thereof with graphical user interface |
| US20240052419A1 (en) * | 2022-08-10 | 2024-02-15 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
| US20240071628A1 (en) * | 2022-08-24 | 2024-02-29 | Guardant Health, Inc. | Database for therapeutic interventions |
-
2015
- 2015-12-28 EP EP15876120.5A patent/EP3240911B1/en active Active
- 2015-12-28 ES ES15876120T patent/ES2828279T3/es active Active
- 2015-12-28 PL PL25155747.6T patent/PL4574996T3/pl unknown
- 2015-12-28 WO PCT/US2015/067717 patent/WO2016109452A1/en not_active Ceased
- 2015-12-28 EP EP25213401.0A patent/EP4715065A2/en active Pending
- 2015-12-28 EP EP25155747.6A patent/EP4574996B1/en active Active
- 2015-12-28 CN CN202111138455.6A patent/CN113930507A/zh active Pending
- 2015-12-28 EP EP22176398.0A patent/EP4123032B1/en active Active
- 2015-12-28 CN CN201580077268.8A patent/CN107406876B/zh active Active
- 2015-12-28 ES ES22176398T patent/ES3017068T3/es active Active
- 2015-12-28 ES ES20179648T patent/ES2923602T3/es active Active
- 2015-12-28 AU AU2015374259A patent/AU2015374259B2/en active Active
- 2015-12-28 GB GB1712299.5A patent/GB2552267B/en active Active
- 2015-12-28 EP EP20179648.9A patent/EP3766986B1/en active Active
- 2015-12-28 JP JP2017535008A patent/JP6783768B2/ja active Active
-
2017
- 2017-02-13 US US15/431,395 patent/US20170260590A1/en active Pending
-
2020
- 2020-04-17 JP JP2020073957A patent/JP7145907B2/ja active Active
- 2020-08-21 US US17/000,010 patent/US20210040565A1/en active Pending
- 2020-11-04 AU AU2020264326A patent/AU2020264326B2/en active Active
-
2021
- 2021-02-02 US US29/768,979 patent/USD1077824S1/en active Active
- 2021-08-31 US US17/462,906 patent/US20210395837A1/en active Pending
- 2021-11-11 JP JP2021184052A patent/JP7458360B2/ja active Active
-
2022
- 2022-03-21 US US17/699,968 patent/US20240141432A9/en active Pending
-
2023
- 2023-07-20 AU AU2023206196A patent/AU2023206196A1/en active Pending
-
2024
- 2024-01-04 JP JP2024000141A patent/JP2024029174A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL4574996T3 (pl) | Wykrywanie i leczenie chorób wykazujących heterogeniczność komórek chorobowych oraz systemy i sposoby przekazywania wyników testów | |
| IL281566A (en) | Methods and systems for diagnosing and treating health ailments | |
| IL272433A (en) | Systems and methods for analysis of tissue images | |
| IL290994A (en) | Methods of diagnosing and treating conduct disorder | |
| PL3798444T3 (pl) | System i sposób detekcji ptaków | |
| EP3001196B8 (en) | Blood testing system and method | |
| IL250521A0 (en) | Method of malware detection and system thereof | |
| EP3182886A4 (en) | System and method for noninvasive analysis of tissue | |
| DK3182901T3 (da) | System og fremgangsmåde til ikke-invasiv analyse af kropsfluider | |
| PL3171765T3 (pl) | Zbieranie i analiza danych do celów diagnostycznych | |
| EP3229668A4 (en) | Device, system and methods for assessing tissue structures, pathology, and healing | |
| PL3242126T3 (pl) | Sposób i system obrazowania promieniowaniem podwójnej energii | |
| DK3202305T3 (da) | Engangsendoskop og system | |
| DK3220973T3 (da) | Kunstigt lungesystem og fremgangsmåder til anvendelse deraf | |
| IL254670A0 (en) | Humanized anti-c1s antibodies and methods of use thereof | |
| IL251121A0 (en) | Methods and systems for diagnostic mapping of bladder | |
| PL3117777T3 (pl) | Metoda tomografii rozpraszającej i urządzenie do tomografii rozpraszającej | |
| BR112017010355A2 (pt) | sistema de monitoramento de paciente, e, método | |
| SG11201703202YA (en) | Method and system for detection of disease agents in blood | |
| IL246658B (en) | Systems and methods for diagnosing sleep | |
| SG11201605105UA (en) | Disease detection system and disease detection method | |
| IL252224B (en) | Systems and methods for performing electrocardiograms | |
| IL251440B (en) | Methods and systems for identifying analytes | |
| DK3177920T3 (da) | På-stedet-diagnosesystem og fremgangsmåde dertil | |
| FR3019217B1 (fr) | Procede et systeme de reactivation rapide de turbomachine |